Ryvu Therapeutics S.A. (WSE: RVU)

Ryvu Therapeutics Revenue

Ryvu Therapeutics had revenue of 25.03M PLN in the quarter ending September 30, 2024, with 54.15% growth. This brings the company's revenue in the last twelve months to 91.18M, up 8.28% year-over-year. In the year 2023, Ryvu Therapeutics had annual revenue of 67.30M, down -1.67%.

• Revenue (ttm): 91.18M
• Revenue Growth: +8.28%
• P/S Ratio: 6.59
• Revenue / Employee: 337.70K
• Employees: 270
• Market Cap: 601.12M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	67.30M	-1.14M	-1.67%
Dec 31, 2022	68.44M	33.02M	93.25%
Dec 31, 2021	35.41M	-1.54M	-4.16%
Dec 31, 2020	36.95M	3.23M	9.58%
Dec 31, 2019	33.72M	-17.96M	-34.75%